Back to Search
Start Over
[Interstitial lung disease in a patient given gemcitabine].
- Source :
-
Revue de pneumologie clinique [Rev Pneumol Clin] 2002 Feb; Vol. 58 (1), pp. 23-6. - Publication Year :
- 2002
-
Abstract
- The differential diagnosis between infectious complications and tumor progression is sometimes difficult in patients given cytotoxic drugs. We report a case of diffuse interstitial lung disease induced by gemcitabine, a new agent used for the treatment of advanced-stage non-small-cell lung cancer.
- Subjects :
- Aged
Antimetabolites, Antineoplastic therapeutic use
Carcinoma, Squamous Cell pathology
Carcinoma, Squamous Cell radiotherapy
Combined Modality Therapy
Deoxycytidine therapeutic use
Diagnosis, Differential
Disease Progression
Humans
Lung Neoplasms pathology
Lung Neoplasms radiotherapy
Male
Neoadjuvant Therapy
Neoplasm Staging
Pulmonary Fibrosis diagnosis
Tomography, X-Ray Computed
Gemcitabine
Antimetabolites, Antineoplastic adverse effects
Carcinoma, Squamous Cell drug therapy
Deoxycytidine adverse effects
Deoxycytidine analogs & derivatives
Lung Neoplasms drug therapy
Pulmonary Fibrosis chemically induced
Subjects
Details
- Language :
- French
- ISSN :
- 0761-8417
- Volume :
- 58
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Revue de pneumologie clinique
- Publication Type :
- Academic Journal
- Accession number :
- 11981501